NewDays
NewDays provides a structured cognitive treatment program for people with mild cognitive impairment or early dementia, combining clinician support with AI-guided brain training exercises. Its approach aims to delay symptom progression, improve cognitive function, and enhance quality of life through clinically validated, non-drug interventions delivered at home.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Technology, Information and Internet
- Founded
- 2024
- Type
- Corporation Seattle business license
- Employees
- 32
- Registered name
- NewDays Inc Seattle business license
- Stage
- Seed
- Members see funding amounts. .
Is this your organization? Claim it
NewDays reports blended telehealth + AI program for MCI associated with ~2.6 years of cognitive delay per treatment year on ACE-III
NewDays reports that their blended program for people with Mild Cognitive Impairment—biweekly telehealth plus daily AI-guided cognitive exercises—was associated with holding or improving cognition over ~7 months, estimating each year of treatment pushed back cognitive symptoms by about 2.6 years on the ACE-III and ~1.6 years on an MMSE-equivalent scale.
People
-
Babak Parviz Executive Officer, Director, Promoter, CEO and Founder at newdays.ai